Middle East and Africa Kidney Disease Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country


No. of Pages: 164    |    Report Code: TIPRE00016075    |    Category: Life Sciences

Explore in Your Language
Middle East and Africa Kidney Disease Market
Buy Now

Market Introduction

Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.

 


Get more information on this report

Middle East and Africa Kidney Disease Strategic Insights

Strategic insights for the Middle East and Africa Kidney Disease provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-kidney-disease-market-strategic-framework.webp
Get more information on this report

Middle East and Africa Kidney Disease Report Scope

Report Attribute Details
Market size in 2019 US$ 4,834.1 Million
Market Size by 2027 US$ 7,406.2 Million
Global CAGR (2020 - 2027) 5.5%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Diagnosis and Treatment
By End User
  • Hospitals
  • Diagnostic Laboratories
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVieInc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Sysmex Corporation
  • Siemens AG
  • Amgen Inc
  • Get more information on this report

    Middle East and Africa Kidney Disease Regional Insights

    The geographic scope of the Middle East and Africa Kidney Disease refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/middle-east-and-africa-kidney-disease-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    TheMiddle East & Africakidney disease market is expected to reach US$ 7,406.2 million in 2027 from US$ 4,834.1million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027.The growth of this market is estimated to grow owing to key driving factors such asrising prevalence of diabetes resulting in renal diseases and rising incidences of renal diseases. However, the market is expected experiencing slow growth during the forecast period owing to the constraint of finance and resources in developing countries.

    Key Market Segments

    Based on product, the kidney disease market is segmented diagnosis and treatment. The diagnosis segment is further sub-segmented into blood tests, urine tests, imaging tests, and others. The treatment segment is further sub-segmented into dialysis, drug class, and others. The drug class is sub-divided into ACE inhibitors, angiotensin-2 receptor blockers, diuretics, and others.Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories,and others.

     

    Major Sources and Companies Listed

    Some of the major primary and secondary sources forkidney disease market included in the report areSaudi Center for Organ Transplantation (SCOT), Kidney International Reports, and others.

     

    Reasons to buy the report

    • To understand the Middle East & Africakidney disease market landscape and identify market segments that are most likely to guarantee a strong return
    • Stay ahead of the race by comprehending the ever-changing competitive landscape for kidney disease market
    • Efficiently plan M&A and partnership deals in Middle East & Africakidney disease market by identifying market segments with the most promising probable sales
    • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment formKidney disease market
    • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Middle East & Africa region

     

    MIDDLE EAST & AFRICAKIDNEY DISEASE MARKET SEGMENTATION

     

    By Product

    ·         Diagnosis

    o      Blood Tests

    o      Urine Tests

    o      Imaging Tests

    o      Others

    ·         Treatment

    o      Dialysis

    o      Others

    o      Drug Class

    §   ACE Inhibitors

    §   Angiotensin-II Receptor Blockers

    §   Diuretics

    §   Others

     

    By End User

    ·         Hospitals

    ·         Diagnostic Laboratories

    ·         Others

     

    By Country

    ·         Middle East & Africa

    o      UAE

    o      Saudi Arabia

    o      South Africa

     

    Company Profiles

    • Abbott
    • F. Hoffmann-La Roche Ltd
    • AbbVieInc
    • Pfizer Inc
    • Teva Pharmaceutical Industries Ltd
    • GlaxoSmithKline plc
    • Sysmex Corporation
    • Siemens AG
    • Amgen Inc
     

    The List of Companies - Middle East and Africa Kidney Disease Market

    The List of Companies - Middle East and Africa Kidney Disease Market

    1. Abbott
    2. F. Hoffmann-La Roche Ltd
    3. AbbVieInc
    4. Pfizer Inc
    5. Teva Pharmaceutical Industries Ltd
    6. GlaxoSmithKline plc
    7. Sysmex Corporation
    8. Siemens AG
    9. Amgen Inc
    Frequently Asked Questions
    How big is the Middle East and Africa Kidney Disease Market?

    The Middle East and Africa Kidney Disease Market is valued at US$ 4,834.1 Million in 2019, it is projected to reach US$ 7,406.2 Million by 2027.

    What is the CAGR for Middle East and Africa Kidney Disease Market by (2020 - 2027)?

    As per our report Middle East and Africa Kidney Disease Market, the market size is valued at US$ 4,834.1 Million in 2019, projecting it to reach US$ 7,406.2 Million by 2027. This translates to a CAGR of approximately 5.5% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa Kidney Disease Market report typically cover these key segments-

    • Product (Diagnosis and Treatment)
    • End User (Hospitals, Diagnostic Laboratories)

    What is the historic period, base year, and forecast period taken for Middle East and Africa Kidney Disease Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Kidney Disease Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Middle East and Africa Kidney Disease Market?

    The Middle East and Africa Kidney Disease Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVieInc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Sysmex Corporation
  • Siemens AG
  • Amgen Inc
  • Who should buy this report?

    The Middle East and Africa Kidney Disease Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Kidney Disease Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now